139 related articles for article (PubMed ID: 18566210)
1. Eps8 decreases chemosensitivity and affects survival of cervical cancer patients.
Chen YJ; Shen MR; Chen YJ; Maa MC; Leu TH
Mol Cancer Ther; 2008 Jun; 7(6):1376-85. PubMed ID: 18566210
[TBL] [Abstract][Full Text] [Related]
2. Epidermal growth factor receptor kinase substrate 8 promotes the metastasis of cervical cancer via the epithelial-mesenchymal transition.
Li Q; Bao W; Fan Q; Shi WJ; Li ZN; Xu Y; Wu D
Mol Med Rep; 2016 Oct; 14(4):3220-8. PubMed ID: 27573546
[TBL] [Abstract][Full Text] [Related]
3. Ganglioside GM3 modulates tumor suppressor PTEN-mediated cell cycle progression--transcriptional induction of p21(WAF1) and p27(kip1) by inhibition of PI-3K/AKT pathway.
Choi HJ; Chung TW; Kang SK; Lee YC; Ko JH; Kim JG; Kim CH
Glycobiology; 2006 Jul; 16(7):573-83. PubMed ID: 16574813
[TBL] [Abstract][Full Text] [Related]
4. Cisplatin restores p53 function and enhances the radiosensitivity in HPV16 E6 containing SiHa cells.
Huang H; Huang SY; Chen TT; Chen JC; Chiou CL; Huang TM
J Cell Biochem; 2004 Mar; 91(4):756-65. PubMed ID: 14991767
[TBL] [Abstract][Full Text] [Related]
5. [Significance and expression of p53, p21(Cip1/WAF1) and Gadd45α in breast neoplasm tissues].
Gao QZ; Fei BJ; Qi XW; Pu Y; Feng YZ
Zhonghua Yi Xue Za Zhi; 2012 Sep; 92(34):2389-93. PubMed ID: 23158659
[TBL] [Abstract][Full Text] [Related]
6. EPS8 regulates proliferation, apoptosis and chemosensitivity in BCR-ABL positive cells via the BCR-ABL/PI3K/AKT/mTOR pathway.
Huang R; Liu H; Chen Y; He Y; Kang Q; Tu S; He Y; Zhou X; Wang L; Yang J; Wu A; Li Y
Oncol Rep; 2018 Jan; 39(1):119-128. PubMed ID: 29192326
[TBL] [Abstract][Full Text] [Related]
7. [Bcl-2 associated athanogene 3 affects the epithelial-mesenchymal transition in human cervical cancer].
Wei L; Qin XP; Zhao XX; Wang W
Zhonghua Fu Chan Ke Za Zhi; 2017 Aug; 52(8):551-557. PubMed ID: 28851173
[No Abstract] [Full Text] [Related]
8. Eps8 facilitates cellular growth and motility of colon cancer cells by increasing the expression and activity of focal adhesion kinase.
Maa MC; Lee JC; Chen YJ; Chen YJ; Lee YC; Wang ST; Huang CC; Chow NH; Leu TH
J Biol Chem; 2007 Jul; 282(27):19399-409. PubMed ID: 17496330
[TBL] [Abstract][Full Text] [Related]
9. Expression of the lncRNA ZFAS1 in cervical cancer and its correlation with prognosis and chemosensitivity.
Feng LL; Shen FR; Zhou JH; Chen YG
Gene; 2019 May; 696():105-112. PubMed ID: 30738960
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-181a enhances the chemoresistance of human cervical squamous cell carcinoma to cisplatin by targeting PRKCD.
Chen Y; Ke G; Han D; Liang S; Yang G; Wu X
Exp Cell Res; 2014 Jan; 320(1):12-20. PubMed ID: 24183997
[TBL] [Abstract][Full Text] [Related]
11. Status of p53 phosphorylation and function in sensitive and resistant human cancer models exposed to platinum-based DNA damaging agents.
Mujoo K; Watanabe M; Nakamura J; Khokhar AR; Siddik ZH
J Cancer Res Clin Oncol; 2003 Dec; 129(12):709-18. PubMed ID: 14513366
[TBL] [Abstract][Full Text] [Related]
12. The phosphatidylinositol 3-kinase/AKT signal transduction pathway plays a critical role in the expression of p21WAF1/CIP1/SDI1 induced by cisplatin and paclitaxel.
Mitsuuchi Y; Johnson SW; Selvakumaran M; Williams SJ; Hamilton TC; Testa JR
Cancer Res; 2000 Oct; 60(19):5390-4. PubMed ID: 11034077
[TBL] [Abstract][Full Text] [Related]
13. Sequential effects of the proteasome inhibitor bortezomib and chemotherapeutic agents in uterine cervical cancer cell lines.
Miyamoto Y; Nakagawa S; Wada-Hiraike O; Seiki T; Tanikawa M; Hiraike H; Sone K; Nagasaka K; Oda K; Kawana K; Nakagawa K; Fujii T; Yano T; Kozuma S; Taketani Y
Oncol Rep; 2013 Jan; 29(1):51-7. PubMed ID: 23064281
[TBL] [Abstract][Full Text] [Related]
14. Msi1 promotes tumor growth and cell proliferation by targeting cell cycle checkpoint proteins p21, p27 and p53 in cervical carcinomas.
Liu X; Yang WT; Zheng PS
Oncotarget; 2014 Nov; 5(21):10870-85. PubMed ID: 25362645
[TBL] [Abstract][Full Text] [Related]
15. Human papilloma virus 16 E6 RNA interference enhances cisplatin and death receptor-mediated apoptosis in human cervical carcinoma cells.
Tan S; Hougardy BM; Meersma GJ; Schaap B; de Vries EG; van der Zee AG; de Jong S
Mol Pharmacol; 2012 May; 81(5):701-9. PubMed ID: 22328720
[TBL] [Abstract][Full Text] [Related]
16. Expression of p21WAF1/CIP1 in adenocarcinoma of the uterine cervix: a possible immunohistochemical marker of a favorable prognosis.
Lu X; Toki T; Konishi I; Nikaido T; Fujii S
Cancer; 1998 Jun; 82(12):2409-17. PubMed ID: 9635534
[TBL] [Abstract][Full Text] [Related]
17. Upregulation of Neural Precursor Cell Expressed Developmentally Downregulated 4-1 is Associated with Poor Prognosis and Chemoresistance in Lung Adenocarcinoma.
Song YH; Zhang CQ; Chen FF; Lin XY
Chin Med J (Engl); 2018 Jan; 131(1):16-24. PubMed ID: 29271375
[TBL] [Abstract][Full Text] [Related]
18. Loss of EPS8 sensitizes non-small-cell lung carcinoma to chemotherapy-induced DNA damage.
Qiu Y; Xu B; Feng J; Wang C; Chen Y; He Y; Xie X; Li Y
Cancer Gene Ther; 2023 Jul; 30(7):997-1006. PubMed ID: 36932195
[TBL] [Abstract][Full Text] [Related]
19. The interplay between Eps8 and IRSp53 contributes to Src-mediated transformation.
Liu PS; Jong TH; Maa MC; Leu TH
Oncogene; 2010 Jul; 29(27):3977-89. PubMed ID: 20418908
[TBL] [Abstract][Full Text] [Related]
20. Protection against chemotherapy-induced cytotoxicity by cyclin-dependent kinase inhibitors (CKI) in CKI-responsive cells compared with CKI-unresponsive cells.
Schmidt M; Fan Z
Oncogene; 2001 Sep; 20(43):6164-71. PubMed ID: 11593424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
